ArticleMedicine2026
Association between the C-Reactive protein-triglyceride-glucose index and osteoarthritis risk in prediabetic mellitus adults: A longitudinal analysis from the China health and retirement longitudinal study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The C-reactive protein-triglyceride-glucose index (CTI) has been identified as a potential new biomarker for insulin resistance and inflammation. However, the association between CTI and osteoarthritis (OA) risk in prediabetic (Pre-DM) individuals from different populations remains unclear. This population-based cohort study included 3043 participants from the China Health and Retirement Longitudinal Study across Waves 1 to 5. The primary endpoint was the incidence of OA events. The associations between the CTI and incident OA incidence were evaluated by competing risk models and Cox regression models, with restricted cubic splines applied to investigate potential nonlinear relationships. To ensure the robustness of the findings, subgroup analyses, multiple imputation, and propensity score methods were also applied. During the 9-year follow-up, 946 (31.09%) participants developed OA. The highest OA risk was observed in the highest CTI quartile (Q4) (HR, 1.376; 95% CI, 1.12, 1.692) in Model 3. A nonlinear relationship between the CTI and OA risk was identified (P for nonlinearity = .012). Subgroup analysis revealed that individuals with a body mass index <24 years and those with a body mass index between 24 and 28 years were more sensitive to the adverse effects of the CTI on OA risk (P for interaction = .012). Furthermore, the association between elevated CTI and OA risk remained consistent across various sensitivity analyses. The CTI can serve as an independent risk marker for predicting the onset of incident OA in middle-aged and older individuals with Pre-DM. Addressing insulin resistance and inflammation may play a crucial role in enhancing primary prevention strategies for OA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.